Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$17.51 USD
-0.25 (-1.41%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.65 |
EPS Last Quarter | 0.61 |
Last EPS Surprise | 7.02% |
ABR | 1.40 |
Earnings ESP
|
1.80% |
---|---|
Current Year | 2.43 |
Next Year | 2.74 |
EPS (TTM) | 2.69 |
P/E (F1) | 7.32 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.08B | 4.19B | 16.25B | 16.84B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 4.16B | 4.38B | 16.39B | 17.30B |
Low Estimate | 3.97B | 4.09B | 16.12B | 16.29B |
Year ago Sales | 3.85B | 4.46B | 15.85B | 16.25B |
Year over Year Growth Est. | 5.86% | -5.92% | 2.56% | 3.64% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.65 | 0.69 | 2.43 | 2.74 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.60 | NA | 2.38 | 2.61 |
High Estimate | 0.67 | 0.70 | 2.46 | 2.98 |
Low Estimate | 0.60 | 0.65 | 2.37 | 2.61 |
Year ago EPS | 0.60 | 1.00 | 2.56 | 2.43 |
Year over Year Growth Est. | 8.33% | -31.00% | -5.08% | 12.89% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 1 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.65 | 0.69 | 2.43 | 2.74 |
7 Days Ago | 0.65 | 0.69 | 2.43 | 2.74 |
30 Days Ago | 0.63 | 0.73 | 2.44 | 2.75 |
60 Days Ago | 0.61 | 0.73 | 2.45 | 2.73 |
90 Days Ago | 0.61 | 0.73 | 2.45 | 2.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.66 | 0.70 | 2.44 | 2.68 |
Zacks Consensus Estimate | 0.65 | 0.69 | 2.43 | 2.74 |
Earnings ESP | 1.80% | 1.45% | 0.55% | -2.19% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.61 | 0.48 | 1.00 | 0.60 | NA |
Estimate | 0.57 | 0.51 | 0.75 | 0.60 | NA |
Difference | 0.04 | -0.03 | 0.25 | 0.00 | 0.07 |
Surprise | 7.02% | -5.88% | 33.33% | 0.00% | 8.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more